Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care. Founded in 2010, MGHIF is a $500M evergreen fund that has invested more than $1bn in 90-plus companies, evergreening the fund twice since its founding.  In addition to financial returns, MGHIF has a proven track record of providing strategic impact for its companies.